Clinical trial
Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
NCT06272981 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation (PAF)
- Lead sponsor
- Biosense Webster, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2024
- Completion date
- October 28, 2025
- Enrollment
- 135 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.